Convection-Enhanced Delivery of Muscimol in Patients with Drug-Resistant Epilepsy

Overview

Journal Neurosurgery

Specialty Neurosurgery

Date 2018 Nov 9

PMID 30407567

Citations 10

Authors

John D Heiss

Davis P Argersinger

William H Theodore

John A Butman

Susumu Sato

Omar I Khan

Affiliations

Soon will be listed here.

Abstract

Background: Minimally invasive therapies for drug-resistant epilepsy (DRE) have been advocated. A study of convection-enhanced delivery (CED) of muscimol, a GABAA receptor agonist, was previously completed in non-human primates.

Objective: To investigate the safety and anti-epileptic effects of intracerebral muscimol infusion into the epileptic focus of patients with DRE.

Methods: In this phase 1 clinical trial, 3 adult patients with DRE underwent CED into the seizure focus of artificial CSF vehicle followed by muscimol for 12 to 24 h each using a crossover design. Basic pathophysiology of the epileptic focus was examined by assessing the infusions' effects on seizure frequency, electroencephalogram (EEG) spike-wave activity, and power-spectral EEG frequency.

Results: Inter-ictal neurological function remained normal in all patients. Pathological examination of resected specimens showed no infusion-related brain injuries. Seizure frequency decreased in 1 of 3 patients during muscimol infusion but was unchanged in all patients during vehicle infusion. Mean beta frequencies did not differ significantly before, during, or after infusion periods. Infused fluid provided insufficient MRI-signal to track infusate distribution. In the 2 yr after standard epilepsy surgery, 1 patient had temporary reduction in seizure frequency and 2 patients were seizure-free.

Conclusion: CED of muscimol into the epileptic focus of patients with DRE did not damage adjacent brain parenchyma or adversely affect seizure surgery outcome. This study did not confirm that intracerebral muscimol infusion effectively suppressed seizures. A surrogate tracer is recommended to track infusion distribution to the epileptic focus and surrounding structures in future studies using CED to suppress the seizure focus.

Citing Articles

Multifunctional fibers enable modulation of cortical and deep brain activity during cognitive behavior in macaques.

Garwood I, Major A, Antonini M, Correa J, Lee Y, Sahasrabudhe A Sci Adv. 2023; 9(40):eadh0974.

PMID: 37801492 PMC: 10558126. DOI: 10.1126/sciadv.adh0974.

Fungal Drug Discovery for Chronic Disease: History, New Discoveries and New Approaches.

Prescott T, Hill R, Mas-Claret E, Gaya E, Burns E Biomolecules. 2023; 13(6).

PMID: 37371566 PMC: 10296638. DOI: 10.3390/biom13060986.

Synthesis of novel sulphamethoxazole derivatives and exploration of their anticancer and antimicrobial properties.

Vaickelioniene R, Petrikaite V, Vaskeviciene I, Pavilonis A, Mickevicius V PLoS One. 2023; 18(3):e0283289.

PMID: 36952512 PMC: 10035904. DOI: 10.1371/journal.pone.0283289.

Fighting Epilepsy with Nanomedicines-Is This the Right Weapon?.

Matias M, Santos A, Silvestre S, Alves G Pharmaceutics. 2023; 15(2).

PMID: 36839629 PMC: 9959131. DOI: 10.3390/pharmaceutics15020306.

An On-Demand Drug Delivery System for Control of Epileptiform Seizures.

Nakano T, Rizwan S, Myint D, Gray J, Mackay S, Harris P Pharmaceutics. 2022; 14(2).

PMID: 35214199 PMC: 8879600. DOI: 10.3390/pharmaceutics14020468.

References

Heiss J, Walbridge S, Morrison P, Hampton R, Sato S, Vortmeyer A . Local distribution and toxicity of prolonged hippocampal infusion of muscimol. J Neurosurg. 2005; 103(6):1035-45. PMC: 4294277. DOI: 10.3171/jns.2005.103.6.1035. View

Song J, Abou-Khalil B, Konrad P . Intraventricular monitoring for temporal lobe epilepsy: report on technique and initial results in eight patients. J Neurol Neurosurg Psychiatry. 2003; 74(5):561-5. PMC: 1738458. DOI: 10.1136/jnnp.74.5.561. View

Laske D, Youle R, Oldfield E . Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med. 1997; 3(12):1362-8. DOI: 10.1038/nm1297-1362. View

Morrison P, Chen M, Chadwick R, Lonser R, Oldfield E . Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol. 1999; 277(4):R1218-29. DOI: 10.1152/ajpregu.1999.277.4.R1218. View

Baraldi M, Grandison L, Guidotti A . Distribution and metabolism of muscimol in the brain and other tissues of the rat. Neuropharmacology. 1979; 18(1):57-62. DOI: 10.1016/0028-3908(79)90009-1. View

Fried I, Wilson C, Maidment N, Engel Jr J, Behnke E, Fields T . Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg. 1999; 91(4):697-705. DOI: 10.3171/jns.1999.91.4.0697. View

LaRiviere M, Gross R . Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy Surgery. Front Surg. 2016; 3:64. PMC: 5136731. DOI: 10.3389/fsurg.2016.00064. View

Chen M, Lonser R, Morrison P, Governale L, Oldfield E . Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg. 1999; 90(2):315-20. DOI: 10.3171/jns.1999.90.2.0315. View

LIEBERMAN D, Laske D, Morrison P, Bankiewicz K, Oldfield E . Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg. 1995; 82(6):1021-9. DOI: 10.3171/jns.1995.82.6.1021. View

10.

Unnerstall J, Pizzi W . Muscimol and gamma-hydroxybutyrate: similar interactions with convulsant agents. Life Sci. 1981; 29(4):337-44. DOI: 10.1016/0024-3205(81)90326-x. View

11.

Krauze M, Saito R, Noble C, Tamas M, Bringas J, Park J . Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg. 2005; 103(5):923-9. PMC: 3816104. DOI: 10.3171/jns.2005.103.5.0923. View

12.

Laske D, Morrison P, LIEBERMAN D, Corthesy M, Reynolds J, Koong S . Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg. 1997; 87(4):586-94. DOI: 10.3171/jns.1997.87.4.0586. View

13.

Shoulson I, Goldblatt D, Charlton M, JOYNT R . Huntington's disease: treatment with muscimol, a GABA-mimetic drug. Ann Neurol. 1978; 4(3):279-84. DOI: 10.1002/ana.410040316. View

14.

Morrison P, Laske D, Bobo H, Oldfield E, Dedrick R . High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol. 1994; 266(1 Pt 2):R292-305. DOI: 10.1152/ajpregu.1994.266.1.R292. View

15.

Theodore W, Spencer S, Wiebe S, Langfitt J, Ali A, Shafer P . Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia. 2006; 47(10):1700-22. DOI: 10.1111/j.1528-1167.2006.00633.x. View

16.

Wieser H, Blume W, Fish D, Goldensohn E, Hufnagel A, King D . ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001; 42(2):282-6. View

17.

During M, Spencer D . Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol. 1992; 32(5):618-24. DOI: 10.1002/ana.410320504. View

18.

. Surgery for epilepsy. Consens Statement. 1990; 8(2):1-20. View

19.

Penn R, Kroin J, Reinkensmeyer A, Corcos D . Injection of GABA-agonist into globus pallidus in patient with Parkinson's disease. Lancet. 1998; 351(9099):340-1. DOI: 10.1016/S0140-6736(05)78336-7. View

20.

Pahapill P, Levy R, Dostrovsky J, Davis K, Rezai A, Tasker R . Tremor arrest with thalamic microinjections of muscimol in patients with essential tremor. Ann Neurol. 1999; 46(2):249-52. DOI: 10.1002/1531-8249(199908)46:2<249::aid-ana15>3.0.co;2-c. View